Results 151 to 160 of about 1,741 (166)

A Phase 1, Randomized, Placebo‐Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Subcutaneous Tezepelumab in Healthy Japanese Men

Clinical Pharmacology in Drug Development, 2020
exaly  

Tezepelumab COPD Exacerbation Study

Case Medical Research, 2019
openaire   +1 more source

Tezepelumab Home Use Study

Case Medical Research, 2019
openaire   +1 more source

Tezepelumab for severe asthma – an “all round” player

European Journal of Internal Medicine
Ophir Freund, Hitasha Rupani, Brian Lipworth, Rory Chan   +3 more
openaire   +2 more sources

Tezepelumab bei schwerem, unkontrolliertem Asthma

Kompass Pneumologie, 2023
openaire   +1 more source

Tezepelumab (Tezspire) for severe asthma.

The Medical letter on drugs and therapeutics, 2022
openaire   +1 more source

Dupilumab/Omalizumab/Tezepelumab

Reactions Weekly
openaire   +1 more source

Cotrimoxazole/dupilumab/tezepelumab

Reactions Weekly
openaire   +1 more source

Tezepelumab in eosinophilic granulomatosis with polyangiitis (EGPA)

Airway pharmacology and treatment
Alexandra Nanzer, Anne-Catherine Maynard-Paquette, Jessica Gates, Faizan Harris, Cris Roxas, Linda Green, Mariana Fernandes, Louise Thomson, Jodie Lam, Grainne D'Ancona, Claire Hopkins, Michelle Fernando, Tevfik Ismail, Jaideep Dhariwal, David Jackson   +14 more
openaire   +1 more source

Short-term therapeutic effectiveness of tezepelumab in patients with severe asthma: A real-world study

International Immunopharmacology
Alessandro Vatrella, Girolamo Pelaia, Corrado Pelaia   +2 more
exaly